Chicago Equity Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-14,430
Closed -$860K 861
2019
Q4
$860K Sell
14,430
-28,860
-67% -$1.78M 0.05% 504
2019
Q3
$2.55M Sell
43,290
-95
-0.2% -$6.06K 0.12% 252
2019
Q2
$2.8M Sell
43,385
-445
-1% -$28.7K 0.12% 235
2019
Q1
$2.78M Sell
43,830
-10,510
-19% -$552K 0.11% 258
2018
Q4
$2.06M Buy
+54,340
New +$1.92M 0.08% 330

Other funds holding TNDM

Chicago Equity Partners's TNDM Position: Q1 2020 in Review

Chicago Equity Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2020, closing a stake of 14,430 shares — an estimated $860K sold.

Chicago Equity Partners first reported a position in TNDM in Q4 2018 and held it in 5 quarters. The position peaked at $2.8M in Q2 2019. 279 funds tracked by Wall St. Rank hold TNDM as of Q1 2020.

  • Chicago Equity Partners reported no remaining Tandem Diabetes Care position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 14,430 Tandem Diabetes Care shares in Q1 2020, an estimated $860K.
  • Chicago Equity Partners first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 5 quarters.
  • Chicago Equity Partners's Tandem Diabetes Care position peaked at $2.8M in Q2 2019.
  • 279 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.